News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Plans New Safety Assessment Of Boehringer Ingelheim Corporation's Pradaxa


1/3/2014 8:22:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

This protocol will guide a one-time assessment of selected safety outcomes in adults with atrial fibrillation who are new users of dabigatran or warfarin. Protocol-based assessments use study designs and analysis plans customized for the product-outcome pairs being assessed. The Mini-Sentinel Operations Center has posted this final draft protocol for public comment. Comments must be received by the Mini-Sentinel Operations Center no later than January 13, 2014. Submit comments by clicking on the Submit Comments link above and filling out the Comment Form or by sending an email directly to info@mini-sentinel.org.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at Forbes

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES